About Michael Detmer
Form D filings for Innovative Therapeutix from 2022 to 2023 list Michael Detmer as chief executive officer and director.
Michael Detmer first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Detmer in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Detmer works with at each company, as listed on that company's latest Form D.
Innovative Therapeutix, Inc. · Form D, Jan 5, 2023
RS
Robert Saunders
Director
RG
Rebekah Gossom
Director